Pre-operative stereotactic radiosurgery and peri-operative dexamethasone for resectable brain metastases: a two-arm pilot study evaluating clinical outcomes and immunological correlates.

Autor: Jansen CS; Department of Urology, Emory University, Atlanta, USA., Pagadala MS; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Cardenas MA; Department of Urology, Emory University, Atlanta, USA., Prabhu RS; Southeast Radiation Oncology Group, Levine Cancer Institute, Atrium Health, Charlotte, USA., Goyal S; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, USA., Zhou C; Department of Radiation Oncology, Emory University, Atlanta, USA.; Winship Cancer Institute, Emory University, Atlanta, USA., Chappa P; Department of Radiation Oncology, Emory University, Atlanta, USA.; Winship Cancer Institute, Emory University, Atlanta, USA., Vo BT; Department of Urology, Emory University, Atlanta, USA., Ye C; Department of Urology, Emory University, Atlanta, USA., Hopkins B; Department of Radiation Oncology, Emory University, Atlanta, USA.; Winship Cancer Institute, Emory University, Atlanta, USA., Zhong J; Department of Radiation Oncology, Emory University, Atlanta, USA.; Winship Cancer Institute, Emory University, Atlanta, USA., Klie A; Biomedical Sciences Program, University of California San Diego, La Jolla, USA., Daniels T; Department of Radiation Oncology, Emory University, Atlanta, USA.; Winship Cancer Institute, Emory University, Atlanta, USA., Admassu M; Department of Radiation Oncology, Emory University, Atlanta, USA.; Winship Cancer Institute, Emory University, Atlanta, USA., Green I; Department of Radiation Oncology, Emory University, Atlanta, USA.; Winship Cancer Institute, Emory University, Atlanta, USA., Pfister NT; Department of Radiation Oncology, University of Alabama Birmingham, Birmingham, AL, USA., Neill SG; Department of Pathology, Emory University, Atlanta, USA., Switchenko JM; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, USA., Prokhnevska N; Department of Urology, Emory University, Atlanta, USA., Hoang KB; Winship Cancer Institute, Emory University, Atlanta, USA.; Department of Neurosurgery, Emory University, Atlanta, USA., Torres MA; Department of Radiation Oncology, Emory University, Atlanta, USA.; Winship Cancer Institute, Emory University, Atlanta, USA., Logan S; Department of Pathology, Nationwide Children's Hospital, Columbus, USA., Olson JJ; Winship Cancer Institute, Emory University, Atlanta, USA.; Department of Neurosurgery, Emory University, Atlanta, USA., Nduom EK; Winship Cancer Institute, Emory University, Atlanta, USA.; Department of Neurosurgery, Emory University, Atlanta, USA., Del Balzo L; Department of Urology, Emory University, Atlanta, USA., Patel K; Kaiser Permanente, Atlanta, USA., Burri SH; Southeast Radiation Oncology Group, Levine Cancer Institute, Atrium Health, Charlotte, USA., Asher AL; Neuroscience Institute, Atrium Health, Charlotte, USA., Wilkinson S; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, USA., Lake R; Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda, USA., Kesarwala AH; Department of Radiation Oncology, Emory University, Atlanta, USA.; Winship Cancer Institute, Emory University, Atlanta, USA., Higgins KA; Department of Radiation Oncology, Emory University, Atlanta, USA.; Winship Cancer Institute, Emory University, Atlanta, USA., Patel P; Department of Radiation Oncology, Emory University, Atlanta, USA.; Winship Cancer Institute, Emory University, Atlanta, USA., Dhere V; Department of Radiation Oncology, Emory University, Atlanta, USA.; Winship Cancer Institute, Emory University, Atlanta, USA., Sowalsky AG; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, USA., Carter H; Department of Medicine, Division of Medical Genetics, University of California San Diego, La Jolla, USA., Khan MK; Department of Radiation Oncology, Emory University, Atlanta, USA.; Winship Cancer Institute, Emory University, Atlanta, USA., Kissick H; Department of Urology, Emory University, Atlanta, USA. haydn.kissick@emory.edu.; Department of Microbiology and Immunology, Emory University, Atlanta, USA. haydn.kissick@emory.edu., Buchwald ZS; Department of Radiation Oncology, Emory University, Atlanta, USA. zbuchwa@emory.edu.; Winship Cancer Institute, Emory University, Atlanta, USA. zbuchwa@emory.edu.

Publikováno v: Nature communications [Nat Commun] 2024 Oct 14; Vol. 15 (1), pp. 8854. Date of Electronic Publication: 2024 Oct 14.

Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trial.

Autor: Bilen MA; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA., Vo BT; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Liu Y; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA., Greenwald R; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Davarpanah AH; Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA, USA., McGuire D; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA.; Emory Vaccine Center, Emory University, Atlanta, GA, USA., Shiradkar R; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA., Li L; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA., Nazha B; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA., Brown JT; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA., Williams S; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Session W; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Russler G; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Caulfield S; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Department of Pharmaceutical Services, Emory University School of Medicine, Atlanta, GA, USA., Joshi SS; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Narayan VM; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Filson CP; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Ogan K; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Kucuk O; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA., Carthon BC; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA., Del Balzo L; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Cohen A; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Boyanton A; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Prokhnevska N; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Cardenas MA; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Sobierajska E; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Jansen CS; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Patil DH; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Nicaise E; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Osunkoya AO; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA.; Department of Pathology, Emory University School of Medicine, Atlanta, GA, USA., Kissick H; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA.; Emory Vaccine Center, Emory University, Atlanta, GA, USA., Master VA; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA.

Publikováno v: Research square [Res Sq] 2024 Aug 08. Date of Electronic Publication: 2024 Aug 08.

A Bayesian Filter for Multi-View 3D Multi-Object Tracking With Occlusion Handling.

Autor: Ong J, Vo BT, Vo BN, Kim DY, Nordholm S

Publikováno v: IEEE transactions on pattern analysis and machine intelligence [IEEE Trans Pattern Anal Mach Intell] 2022 May; Vol. 44 (5), pp. 2246-2263. Date of Electronic Publication: 2022 Apr 01.

Ultra-Deep Massive Parallel Sequencing of Plasma Cell-Free DNA Enables Large-Scale Profiling of Driver Mutations in Vietnamese Patients With Advanced Non-Small Cell Lung Cancer.

Autor: Tran LS; Gene Solutions, Ho Chi Minh City, Vietnam., Nguyen QT; Medical Genetics Institute, Ho Chi Minh City, Vietnam., Nguyen CV; Vietnam National Cancer Hospital, Hanoi, Vietnam., Tran VU; Gene Solutions, Ho Chi Minh City, Vietnam., Nguyen TT; Vietnam National Cancer Hospital, Hanoi, Vietnam., Le HT; Ha Noi Oncology Hospital, Hanoi, Vietnam., Nguyen MT; Ha Noi Oncology Hospital, Hanoi, Vietnam., Le VT; Cho Ray Hospital, Ho Chi Minh City, Vietnam., Pham LS; Vietnam National Cancer Hospital, Hanoi, Vietnam., Vo BT; Gene Solutions, Ho Chi Minh City, Vietnam., Dang AH; University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam., Nguyen LT; Gene Solutions, Ho Chi Minh City, Vietnam., Nguyen TV; Gene Solutions, Ho Chi Minh City, Vietnam., Pham HT; Gene Solutions, Ho Chi Minh City, Vietnam., Tran TT; Gene Solutions, Ho Chi Minh City, Vietnam., Nguyen LH; Gene Solutions, Ho Chi Minh City, Vietnam., Nguyen TT; Gene Solutions, Ho Chi Minh City, Vietnam., Nguyen KT; Gene Solutions, Ho Chi Minh City, Vietnam., Vu YV; Gene Solutions, Ho Chi Minh City, Vietnam., Nguyen NH; Gene Solutions, Ho Chi Minh City, Vietnam., Bui VQ; Ha Noi Oncology Hospital, Hanoi, Vietnam., Bui HH; HT Genetics, Ho Chi Minh City, Vietnam., Do TT; Medical Genetics Institute, Ho Chi Minh City, Vietnam., Lam NV; University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam., Truong Dinh K; Medical Genetics Institute, Ho Chi Minh City, Vietnam., Phan MD; Gene Solutions, Ho Chi Minh City, Vietnam., Nguyen HN; University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam., Giang H; Gene Solutions, Ho Chi Minh City, Vietnam.

Publikováno v: Frontiers in oncology [Front Oncol] 2020 Aug 04; Vol. 10, pp. 1351. Date of Electronic Publication: 2020 Aug 04 (Print Publication: 2020).

Actionable Mutation Profiles of Non-Small Cell Lung Cancer patients from Vietnamese population.

Autor: Dang AH; University of Medicine and Pharmacy at Ho Chi Minh city, Ho Chi Minh city, Vietnam., Tran VU; Gene Solutions, Ho Chi Minh city, Vietnam., Tran TT; Gene Solutions, Ho Chi Minh city, Vietnam., Thi Pham HA; Gene Solutions, Ho Chi Minh city, Vietnam., Le DT; Pham Ngoc Thach Hospital, Ho Chi Minh city, Vietnam., Nguyen L; Pham Ngoc Thach Hospital, Ho Chi Minh city, Vietnam., Nguyen NV; Pham Ngoc Thach Hospital, Ho Chi Minh city, Vietnam., Thi Nguyen TH; Vietnam National Cancer Hospital, Ha Noi, Vietnam., Nguyen CV; Vietnam National Cancer Hospital, Ha Noi, Vietnam., Le HT; Ha Noi Oncology hospital, Ha Noi, Vietnam., Thi Nguyen ML; Ha Noi Oncology hospital, Ha Noi, Vietnam., Le VT; Cho Ray hospital, Ho Chi Minh City, Vietnam., Nguyen PH; University of Medicine and Pharmacy at Ho Chi Minh city, Ho Chi Minh city, Vietnam., Vo BT; Gene Solutions, Ho Chi Minh city, Vietnam., Thi Dao HT; Gene Solutions, Ho Chi Minh city, Vietnam., Nguyen LT; Gene Solutions, Ho Chi Minh city, Vietnam., Van Nguyen TC; Gene Solutions, Ho Chi Minh city, Vietnam., Bui QN; Gene Solutions, Ho Chi Minh city, Vietnam., Nguyen LH; Gene Solutions, Ho Chi Minh city, Vietnam., Nguyen NH; Gene Solutions, Ho Chi Minh city, Vietnam., Thi Nguyen QT; Medical Genetics Institute, Ho Chi Minh City, Vietnam., Le TX; University of Medicine and Pharmacy at Ho Chi Minh city, Ho Chi Minh city, Vietnam., Do TT; University of Medicine and Pharmacy at Ho Chi Minh city, Ho Chi Minh city, Vietnam., Dinh KT; Medical Genetics Institute, Ho Chi Minh City, Vietnam., Do HN; Gene Solutions, Ho Chi Minh city, Vietnam., Phan MD; Gene Solutions, Ho Chi Minh city, Vietnam.; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia., Nguyen HN; University of Medicine and Pharmacy at Ho Chi Minh city, Ho Chi Minh city, Vietnam. nhnghia81@gmail.com., Tran LS; Gene Solutions, Ho Chi Minh city, Vietnam. leson1808@gmail.com.; Institute of Molecular and Cellular Biology, Astar, Singapore. leson1808@gmail.com., Giang H; Gene Solutions, Ho Chi Minh city, Vietnam. gianghoa@gmail.com.; Medical Genetics Institute, Ho Chi Minh City, Vietnam. gianghoa@gmail.com.

Publikováno v: Scientific reports [Sci Rep] 2020 Feb 17; Vol. 10 (1), pp. 2707. Date of Electronic Publication: 2020 Feb 17.